State-of-the-Art: Developing Functional Biodegradable Materials for Biomedical Applications to prevent the long-term adverse effects due to the non-degradability of nanomaterials and for better clinical translation of biomaterials (e.g., Au, Ag, CNTs accumulated in the liver and spleen).

We employ 2D materials such as graphene oxide, MoS2, MXenes, etc., in combination with biopolymers or biominerals for developing degradable biomaterials for Drug/Gene Delivery, Nanotheranostics, Biomimetic Systems, and Antimicrobial Coatings to tackle multidrug resistance bacteria including pandemic virus-like COVID-19.

Biodegradable Drug Carriers: Hybrid Nanoparticles for Synergistic Chemo-photothermal Therapy (Funded by the DBT-Ramalingaswami Fellowship 2020-21)

Biodegradability of Nanomaterials: Evaluation of the ability of peroxidases secreted by immune cells to oxidize/degrade the emerging 2D materials such as black phosphorus, MXenes, etc., and intracellular (macrophages) stability of 2D materials and their cytotoxicity.  E.g., Biodegradation of Graphene by human enzymes. (Funded by SERB through Start-up Research Grant 2022 for the next 2 years) https://onlinelibrary.wiley.com/doi/10.1002/cnma.202300630

Development of sustainable Bioplastics from biomass and their biodegradations. Polymer recycling and microplastic degradations.